MENDUS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4745 SEK | +0.96% |
|
-5.10% | -9.27% |
| Apr. 16 | Mendus AB Announces Board Changes | CI |
| Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
Chart calendar Mendus AB
e0a8b63638a91bf8e9983a5f82f2e4a.PpWmoFV2l6SrtiIFn-UMb9H44bYszrM4QO7v9NWT0kY.dsHw6RA979Hlx3Fcz6E8K4KeqONjpclvGNybrYaqkxxb9OHIHUPiif7UGg~e81af855534abb0648b27ad9c6806662
Upcoming events on Mendus AB
Past events on Mendus AB
| 2024-03-18 | Innate Killer Summit |
| 2024-03-12 10:00 am | Business Update Call |
| 2024-02-26 | IO360° Summit |
| 2024-02-14 04:00 am | Q4 2023 Earnings Call |
| 2024-02-14 02:00 am | Q4 2023 Earnings Release |
| 2024-01-24 04:55 am | Redeye Theme: Fight Cancer |
| 2024-01-07 | LifeSci Partners Corporate Access Event |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-14 09:00 am | Investor Meeting - Key Opinion Leader |
| 2023-12-13 10:00 am | Extraordinary Shareholders Meeting |
| 2023-12-11 01:30 pm | American Society of Hematology Meeting - Abstract No:769 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No:2942 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No:2957 |
| 2023-12-05 05:40 am | Cell & Gene Therapy Manufacturing & Commercialization Conference |
| 2023-11-23 10:30 am | Redeye Life Science Day |
| 2023-11-20 | Belgian Dutch Immunology Meeting |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-12 | Investival Showcase |
| 2023-11-09 04:00 am | Q3 2023 Earnings Call |
| 2023-11-09 02:00 am | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,03 0,00 - | 3,38 1,61 110.15% | 29,6 0,41 7149.2% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -132 -120 -10.36% | 0,00 | -130 -130 0.17% | -132 -127 -3.62% | -89,8 -115 22.17% | -129 |
|
EBIT Million SEK | Released Forecast Spread | -132 -120 -10.36% | -86,0 | -130 -130 0.17% | -134 -127 -4.97% | -101 -117 14.23% | -130 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -134 -120 -11.78% | -89,2 | -133 -132 -1.15% | -139 -129 -7.21% | -102 -106 4.2% | -130 |
|
Net income Million SEK | Released Forecast Spread | -134 -120 -11.78% | -89,2 | -133 -132 -1.15% | -139 -129 -7.21% | -102 -106 4.2% | -130 |
|
EPS SEK | Released Forecast Spread | -1,50 -1,34 -11.94% | -1,17 | -0,73 -0,68 -8.15% | -0,70 -0,63 -11.11% | -0,22 -0,14 -57.14% | -0,12 |
| Announcement Date | 18/02/20 | 18/02/21 | 17/02/22 | 17/02/23 | 14/02/24 | - |
More events
Past sector events for Mendus AB
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMMU Stock
- Calendar Mendus AB
